International AIDS Vaccine Initiative | IAVI - International AIDS Vaccine Initiative

XVII International AIDS Conference

The XVII International AIDS Conference (AIDS 2008) will be held in Mexico City, Mexico from 3-8 August 2008. AIDS 2008 will be the first time a country in Latin America has hosted the Conference, and IAVI will be there to participate in a series of events, as well as to report on the state of AIDS vaccine research and development.
READ MORE >

HIV/AIDS: The Search for a Vaccine

Originally aired as part of BBC World’s Kill or Cure? series, this four-minute documentary features AIDS specialists, researchers, and community workers discussing the impact of HIV/AIDS on their communities and their efforts to find a solution to the epidemic.
WATCH THE VIDEO
DOWNLOAD THE PODCAST

Why the world needs an AIDS vaccine

Despite the international community's best efforts, the HIV pandemic continues unabated. In 2006, more than 39 million people were living with HIV worldwide. Over four million people became newly infected with HIV and an estimated 2.8 million lost their lives to AIDS.
LEARN MORE >

What is a vaccine?

A vaccine is a substance that is introduced into the body to prevent infection or to control disease due to a certain pathogen (any disease-causing organism, such as a virus, bacterium or parasite); the vaccine 'teaches' the body how to defend itself against a pathogen by creating an immune response.
LEARN MORE >

Latest News

^{[what's this?]}

IAVI and Indian Government Announce Results of Phase I AIDS Vaccine Trial

A phase I clinical trial of an MVA-based AIDS vaccine candidate was successfully completed in India, the results of which showed the vaccine candidate had acceptable levels of safety and was well tolerated.

Inovio Expands Research Agreement with IAVI for Use of Novel Vaccine Delivery Technology

As part of an expanded agreement, Inovio Biomedical Corporation will supply IAVI with electroporation delivery devices for use in pre-clinical research on HIV genes and AIDS vaccine candidates. This technology that has the potential to induce significant antibody and T-cell immune responses, both of which scientists believe will be critical to developing a preventive AIDS vaccine.

Mexico City AIDS 2008: Luminaries Call for an AIDS Vaccine to End the Epidemic

Discussions about how to manage AIDS in the long term and how to improve prevention efforts globally took center stage at this year's International AIDS Conference held in Mexico City, with luminaries and vaccine advocates alike calling for continued support for an AIDS vaccine to end the epidemic.

IAVI Launches 2008 AIDS Vaccine Blueprint in Mexico City

With the release of its biennial AIDS Vaccine Blueprint 2008 at the International AIDS Conference today in Mexico City, IAVI seeks to reset both expectations and focus in the search for an AIDS vaccine. A recording of the press conference is available at www.iavi.org/pressbriefing.

A Vaccine is Essential to Eliminating AIDS

In an opinion piece published in the Boston Globe, First Lady of Rwanda and High Representative for the African AIDS Vaccine Program Jeannette Kagame and IAVI President and CEO Dr. Seth Berkley together call for patience, perseverance and continued investment in the search for an AIDS vaccine.

New Resource Tracking Report Released

A new HIV vaccines and microbicides resource tracking report, released at the International AIDS Conference in Mexico City, indicates a dramatic increase in funding for biomedical HIV prevention research and development, including AIDS vaccines and microbicides, between 2000 and 2006—with only a modest increase in 2007.

MORE NEWS >